Bayesian Optimization in Drug Discovery.

Area of Science:

• Computational Chemistry
• Drug Design
• Machine Learning in Pharmacology

Background:

• Drug discovery involves iterative optimization of candidate molecules.
• Current optimization methods often rely on extensive trial-and-error processes.
• In silico approaches are crucial for accelerating the drug discovery pipeline.

Purpose of the Study:

• To introduce Bayesian optimization (BO) as a powerful tool for drug design.
• To explain the principles and algorithmic components of BO for drug discovery.
• To highlight practical applications and solutions for BO within drug discovery constraints.

Main Methods:

• Exploration of black-box optimization concepts in drug design.
• Detailed explanation of Bayesian optimization principles and algorithms.
• Focus on adapting BO to the specific constraints of pharmaceutical research.

Main Results:

• Demonstration of BO's effectiveness in determining optimal functions for drug candidates.
• Presentation of accessible explanations for implementing BO in drug discovery projects.
• Compilation of diverse practical applications of BO in the field.

Conclusions:

• Bayesian optimization offers a significant advancement over traditional trial-and-error methods in drug discovery.
• BO provides a robust framework for optimizing drug candidates efficiently.
• The chapter equips researchers with the knowledge to apply BO in their drug design endeavors.